Company: LIMN
Filing Date: 2025-01-27
Form Type: POS AM
Source: 0001104659-25-006325
Chunk: 274

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-27
Form: POS AM
Chunk 274
---
 a single class, to approve amendments to the Liminatus Bylaws and amendments to certain provisions of the Proposed ParentCo Certificate of Incorporation if any such amendment was not approved by at least two-thirds (2/3) of the Board of Liminatus. The Iris Board believes that requiring the approval by the affirmative vote of holders of at least two-thirds of the voting power of Liminatus’s then-outstanding shares of capital stock entitled to vote in an election of directors to make any amendment to the Liminatus Bylaws or to certain provisions of the Proposed ParentCo Certificate of Incorporation that were not approved by the ParentCo Board is intended to protect key provisions of the Proposed ParentCo Certificate of Incorporation and the Liminatus Bylaws, respectively, from arbitrary amendment and to prevent a simple majority of stockholders from taking actions that may be harmful to other stockholders or making changes to provisions that are intended to protect all stockholders.

The approval of each of the Advisory Charter Proposals requires the affirmative vote of the holders of a majority of the shares of Iris common stock cast in respect of the relevant Proposal and entitled to vote thereon at the Special Meeting, voting together as a single class. An abstention will be counted towards the quorum requirement but will not count as a vote cast at the Special Meeting. A broker non-vote will neither be counted towards the quorum requirement (as we believe the Advisory Charter Proposals will be considered as non-discretionary) nor count as a vote cast in the Special Meeting.

A copy of the Proposed ParentCo Certificate of Incorporation, as will be in effect and upon consummation of the Business Combination and filing with the Delaware Secretary of State, is attached to this proxy statement/prospectus as Annex C .

#### Recommendation of the Board

### THE IRIS BOARD UNANIMOUSLY RECOMMENDS THAT
<div align='center'>IRIS STOCKHOLDERS VOTE “FOR” EACH OF THE ADVISORY CHARTER PROPOSALS.

134</div>

TABLE OF CONTENTS

<div align='center'>**PROPOSAL NO. 6 — THE ELECTION OF DIRECTORS PROPOSAL**</div>

### Overview
Iris stockholders are being asked to consider, approve and confirm, on an advisory and non-binding basis, the appointment by the Iris Board of the following three directors to the ParentCo board of directors, effective upon the closing:

As a Class I director, with a term expiring at ParentCo’s 2026